It is a pharma foreign private limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 | Mumbai, Maharashtra, India | ActiveSinclair Lifesciences India Private Limited, a active foreign private limited company, was established on 12 May 2011 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100MH2011FTC217375. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.48 M.
Its leadership includes Jayne Katherine Burrell (Director), Sharath Kumar Srinivasa Annur (Director), Alan Musgrave Olby (Director). Past directors included Stephen Michael Redman, Talur Pompapathy Shivaprasad. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Topiwala Center, Cts No. 746/7, Village-Pahadi, Ground Floor, Shop No. 50, Goregaon (W), Mumbai, Maharashtra, 400062.
U24100MH2011FTC217375
217375
12 May 2011
₹1.00 M
₹0.48 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sinclair Lifesciences India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayne Katherine Burrell | Director | 22 Apr 2022 | Current |
| Sharath Kumar Srinivasa Annur | Director | 10 Jun 2014 | Current |
| Alan Musgrave Olby | Director | 12 May 2011 | Current |
| Talur Pompapathy Shivaprasad | Director | 05 Sep 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Feb 2020 | Past |
| Pramod Abcsdd | Director | 10 Oct 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sinclair Lifesciences India Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 2.5% increase in profit. The company's net worth dipped by a decrease of 3.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2019, Sinclair Lifesciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sinclair Lifesciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sinclair Lifesciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sinclair Lifesciences India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jayne Katherine Burrell was appointed as a Director was appointed as a Director on 22 Apr 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Sinclair Lifesciences India Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
The activity Sinclair Lifesciences India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was completed.
Progress on Sharath Kumar Srinivasa Annur was appointed as a Director was appointed as a Director on 10 Jun 2014 & has been associated with this company since 11 years 5 months . was documented.
The activity Talur Pompapathy Shivaprasad was appointed as a Director was appointed as a Director on 05 Sep 2013 & has been associated with this company since 12 years 2 months . was completed.
The activity Alan Musgrave Olby was appointed as a Director was appointed as a Director on 12 May 2011 & has been associated with this company since 14 years 6 months . was completed.
The CIN of Sinclair Lifesciences India Private Limited is U24100MH2011FTC217375.
Sinclair Lifesciences India Private Limited is headquartered at Topiwala Center, Cts No. 746/7, Village-Pahadi, Ground Floor, Shop No. 50, Goregaon (W), Mumbai, Maharashtra, 400062.
Sinclair Lifesciences India Private Limited was incorporated on 12 May 2011.
The current directors of Sinclair Lifesciences India Private Limited are
The primary industry of Sinclair Lifesciences India Private Limited is Trade.
Sinclair Lifesciences India Private Limited is unlisted.
The authorized capital of Sinclair Lifesciences India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.48 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX